| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.078 | 0.03 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.14 | 0.03 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.03 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.03 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.078 | 0.03 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.03 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.08 | 0.04 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.04 |